More than half of the new HIV infections occur in women in developing countries, but only about 20% of the participants in phase I and II HIV vaccine trials are women. This makes it difficult for researchers to determine if the virus is actually effective in women. It's thought that this may be due to a couple factors - the first that women can not become pregnant during the trial, but most eligible women are usually within the reproductive age; second, women may need to seek consent from their parents or partners to participate in the trial and this may influence their willingness to participate.
http://www.nature.com/news/hiv-vaccine-trials-struggle-to-enrol-women-1.11415
Same article also on SciDev.Net (I'm not sure if access to the articles is different)
http://www.scidev.net/en/health/hiv-aids/news/hiv-vaccine-trials-struggle-to-enrol-women.html
No comments:
Post a Comment